SCHEMBL5811099

SCHEMBL5811099

O=C(NCc1ccc2c(c1)CCO2)N1CCC1OC(Cl)(c1ccccc1)c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.45
POLB P06746 2/20 0.45
NPC1 O15118 1/20 0.45
CHRM5 P08912 5/20 0.44
CHRM1 P11229 5/20 0.44
CHRM4 P08173 3/20 0.44
CHRM3 P20309 3/20 0.44
CHRM2 P08172 2/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
ADRA2A P08913 1/20 0.44
DRD2 P14416 1/20 0.44
KCNE1 P15382 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
HRH2 P25021 1/20 0.44
HTR2A P28223 1/20 0.44
SLC6A4 P31645 1/20 0.44
ADRA1A P35348 1/20 0.44
OPRM1 P35372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5814015 0.81 GLA (0.46) POLBMAPTHRH3CASP3
SCHEMBL5811091 0.79 RAB9A (0.46) RAB9APOLBNPC1CHRM5CHRM1
SCHEMBL5811095 0.77 RAB9A (0.44) RAB9APOLBNPC1CHRM5CHRM1
SCHEMBL5803269 0.76 TDP1 (0.45) RAB9APOLBNPC1OPRM1
SCHEMBL5816787 0.76 PKM (0.45) POLBMAPT
SCHEMBL5821905 0.75 FABP3 (0.43) RAB9APOLBNPC1MAPT
SCHEMBL5811093 0.72 CHRM5 (0.40) RAB9APOLBNPC1CHRM5CHRM1
SCHEMBL10107719 0.69 ALDH2 (0.68) RAB9APOLBNPC1CHRM4MAPT
SCHEMBL3620383 0.66 RAB9A (0.70) RAB9APOLBNPC1CHRM4MAPT
SCHEMBL14001605 0.65 CHRM5 (0.79) RAB9APOLBNPC1CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620395-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2006-02-01 EP disclosed
WO-2004096763-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2004-11-11 WO disclosed